About Metrolina Medical Research
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Metrolina Medical Research
During the past decade, Metrolina Medical Research conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
2014-08-18
2026-10-10
Active, not recruiting
450
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
2014-08-18
Recruiting
8,300
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
2014-08-18
2036-05-01
Recruiting
168
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma
2015-07-13
2023-10-02
Active, not recruiting
300
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma
2015-09-10
2033-06-30
Recruiting
600
Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy
2015-04-29
2031-03-29
Active, not recruiting
415
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
2015-08-12
2025-12-31
Active, not recruiting
6,452
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Metrolina Medical Research" #1 sponsor was "AstraZeneca" with 7 trials, followed by "Mannkind Corporation" with 2 trials
sponsored, "Orexigen Therapeutics, Inc" with 2 trials sponsored, "Purdue Pharma LP" with 2 trials sponsored and "Allergan"
with 2 trials sponsored. Other sponsors include 6 different institutions and
companies that sponsored additional 16 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Metrolina Medical Research"
#1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Integrium" with 1 trials as a collaborator, "RTI Health Solutions" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Metrolina Medical Research
According to Clinical.Site data, the most researched conditions in "Metrolina Medical Research" are
"Diabetes Mellitus, Type 2" (3 trials), "Back Pain Lower Back Chronic" (2 trials), "Obesity" (2 trials), "Overweight" (2 trials) and "Type 2 Diabetes" (2 trials). Many other conditions were trialed in "Metrolina Medical Research" in a lesser frequency.
Clinical Trials Intervention Types at Metrolina Medical Research
Most popular intervention types in "Metrolina Medical Research" are "Drug" (24 trials), "Behavioral" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "AC2993" (3 trials), "placebo" (3 trials), "Ancillary therapy" (2 trials) and "Dapagliflozin" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Metrolina Medical Research
The vast majority of trials in "Metrolina Medical Research" are
24 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Metrolina Medical Research
Currently, there are NaN active trials in "Metrolina Medical Research".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 21 completed trials in Metrolina Medical Research,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Metrolina Medical Research, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 18 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".